JAGRX
Price
$55.76
Change
-$0.15 (-0.27%)
Updated
Sep 20 closing price
RGEBX
Price
$73.82
Change
-$0.14 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

JAGRX vs RGEBX

Header iconJAGRX vs RGEBX Comparison
Open Charts JAGRX vs RGEBXBanner chart's image
Janus Henderson VIT Research Instl
Price$55.76
Change-$0.15 (-0.27%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$73.82
Change-$0.14 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JAGRX vs RGEBX Comparison Chart
Loading...
VS
JAGRX vs. RGEBX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGRX is a Buy and RGEBX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 290B vs. JAGRX (696M). RGEBX pays higher dividends than JAGRX: RGEBX (0.16) vs JAGRX (0.11). JAGRX was incepted earlier than RGEBX: JAGRX (31 years) vs RGEBX (10 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. JAGRX (27.00). JAGRX has a lower initial minimum investment than RGEBX: JAGRX (0) vs RGEBX (250). JAGRX annual gain was more profitable for investors over the last year : 33.46 vs. RGEBX (22.86). RGEBX (47.60) and JAGRX (47.00) have equivalent 5 years return.
JAGRXRGEBXJAGRX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years10 years-
Gain YTD21.07618.896112%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets696M290B0%
Annual Yield % from dividends0.110.1668%
Returns for 1 year33.4622.86146%
Returns for 3 years1.14-4.80-24%
Returns for 5 years47.0047.6099%
Returns for 10 years64.6956.25115%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLNE158.621.25
+0.79%
Hamilton Lane
IE7.390.03
+0.41%
Ivanhoe Electric
HLN10.55-0.10
-0.94%
Haleon plc
COMM5.60-0.08
-1.41%
CommScope Holding Company
QNCX0.74-0.02
-2.65%
Quince Therapeutics